Locust Walk to Co-Host Allicense 2015, May 5 – 6 in San Francisco
CATEGORIES News Events Publications ARCHIVE Locust Walk to Co-Host Allicense 2015, May 5 – 6 in San Francisco Building off […]
Events
2014
News
Strategic Science & Technologies Signs Partnership Agreement with a Leading Global Pharmaceutical Company for U.S. Commercial Rights to Topical Ibuprofen
CATEGORIES News Events Publications ARCHIVE Strategic Science & Technologies Signs Partnership Agreement with a Leading Global Pharmaceutical Company for U.S.
News
TesoRx and Aspen Group Conclude Investment and Licensing Agreement
CATEGORIES News Events Publications ARCHIVE TesoRx and Aspen Group Conclude Investment and Licensing Agreement (Menlo Park, CA, United States and
News
Armetheon Announces Close of $7M Series A Financing
CATEGORIES News Events Publications ARCHIVE Armetheon Announces Close of $7M Series A Financing The Locust Walk Partners team is proud
News
Senesco Completes Acquisition of Fabrus
CATEGORIES News Events Publications ARCHIVE SENESCO COMPLETES ACQUISITION OF FABRUS PRESS RELEASE MAY 19, 2014 8:30 AM BRIDGEWATER, N.J.–(BUSINESS WIRE)–
Events
Locust Walk Partners Co-hosts, NYBio Annual Meeting Pitch & Partner Session May 14, 2014
CATEGORIES Asian Capabilities Capital Raising Commercial Assessment ARCHIVE Locust Walk Partners Co-hosts, NYBio Annual Meeting Pitch & Partner Session May
Events
Allicense 2014: Chris Ehrlich, Managing Director, Locust Walk Partners moderates a Panel Discussion: “The Great Divide – Public vs Private Investing in Life Sciences”
CATEGORIES News Events Publications ARCHIVE Allicense 2014: Chris Ehrlich, Managing Director, Locust Walk Partners moderates a Panel Discussion: “The Great
Events
Allicense 2014: Jay Mohr, Managing Director & Co-Founder, Locust Walk Partners, moderates the panel discussion: “Partnering Returned Assets – Understanding Strategies to Maximize Value”
CATEGORIES News Events Publications ARCHIVE Allicense 2014: Jay Mohr, Managing Director & Co-Founder, Locust Walk Partners, moderates the panel discussion:
News
BioWorld: 2013 dealmaking hit $158B with a focus on early stage assets: Michael Fitzhugh, Staff Writer
CATEGORIES News Events Publications ARCHIVE BioWorld: 2013 dealmaking hit $158B with a focus on early stage assets: Michael Fitzhugh, Staff
Events
Allicense 2014: Jay Mohr, Managing Director & Co-Founder, Locust Walk Partners will moderate the panel discussion: “Partnering Returned Assets – Understanding Strategies to Maximize Value”
CATEGORIES Asian Capabilities Capital Raising Commercial Assessment ARCHIVE Allicense 2014: Jay Mohr, Managing Director & Co-Founder, Locust Walk Partners will